Pharma Focus Asia

Eli Lilly Invests US$1 billion to Open New Manufcaturing Facility


Eli Lilly plans for the construction of new manufacturing site. The new site will be located in North California.


The new facility will be designed with latest technologies to manufacture  parenteral (injectable) products and devices including medicines.

The manufacuturing facility enables to produce today's medicinesand on the other hand, additional capacity will be dedicated for the manufacturingof medicines infuture. In addition, the facility benefits the people around the globe by providing more medicinesto address health challenges.

The construction of the new facility strengthens relationships with local governments and universities and expand its growing presence in the state.

The facility is expected to create approximately 600 new jobs for highly skilled workers such as scientists, engineers and manufacturing personnel. Moreover, additional 500 positions will be neededduring construction.


NameEli Lilly and Company
TypeNew Construction
BudgetUS$1 billion
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Thermo Fisher Scientific - Rapid Mycoplasma TestingAsia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024The Drug Safety Symposium 2024Medlab Middle East 2024ISPE Singapore Affiliate Conference & Exhibition 2024